RxDoctor Payments Data

Kristen Hodges

Surgical · Edmond, OKNPI 1609046416

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Stryker at 33.2% of the total. 2025 is the largest year on record at $280, 7.9 times the $36 reported in 2021.

$857in general payments, 2019–2025

Across 19 payments — averaging $45.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$284
  • Nalu Medical, Inc.$153
  • Pylant Medical$74
  • Vericel Corporation$66
  • Si-bone, Inc.$63
  • Smith+Nephew$61
  • plus $155 from 5 others

What the payments were for

  • Food & beverage$857100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$857 in reported general payments places this provider in the 65th percentile of 94 surgical providers in Oklahoma.

See all surgical providers in Oklahoma

Medicare billing

Part B allowed, 2024
$31,115
Medicare patients
183
Services billed
644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam96$318
Celecoxib19$240
Methylprednisolone15$134

Paid to pharmacies, not to this prescriber.

Other surgical in Edmond

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →